Silvia Gónzalez-Pelayo

Prof. Dr. Silvia Gónzalez-Pelayo

orcid
Assistant Professor at the Faculty of Pharmacy, Department o...

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ISIrene G. Salado
Irene G. Salado
JZJosefa Zaldivar-Diez
Josefa Zaldivar-Diez
VSVíctor Sebastián-Pérez
Víctor Sebastián-Pérez
LLLingling Li
Lingling Li
LGLarissa Geiger
Larissa Geiger
Ana MartinezAna Martinez
Ana Martinez
Leucine-rich repeat kinase 2 (LRRK2) is one of the most pursued targets for Parkinson's disease (PD) therapy. Moreover, it has recently described its role in regulating Wnt signaling and thus, it may be involved in adult neurogenesis. This new hypothesis could give rise to double disease-modifying agents firstly by the benefits of inhibiting LRRK2 and secondly by promoting adult neurogenesis. Herein we report, the design, synthesis, biological evaluation, SAR and potential binding mode of indoline-like LRRK2 inhibitors and their preliminary neurogenic effect in neural precursor cells isolated from adult mice ventricular-subventricular zone. These results open new therapeutic horizons for the use of LRRK2 inhibitors as neuroregenerative agents. Moreover, the indolinone derivatives here prepared, inhibitors of the kinase activity of LRRK2, may be considered as pharmacological probes to study the potential neuroregeneration of the damaged brain.

26 October 2017 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
Silvia Gónzalez-PelayoSilvia Gónzalez-Pelayo
Silvia Gónzalez-Pelayo
LLLuis López
Luis López


15 June 2018 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
Silvia Gónzalez-PelayoSilvia Gónzalez-Pelayo
Silvia Gónzalez-Pelayo
ELEnol Lopez
Enol Lopez
JBJavier Borge
Javier Borge
Noemí de-los-Santos-ÁlvarezNoemí de-los-Santos-Álvarez
Noemí de-los-Santos-Álvarez
LLLuis López
Luis López

1 June 2018 in Molecules
Verified
Journal Article
Open access
PDF file
Silvia Gónzalez-PelayoSilvia Gónzalez-Pelayo
Silvia Gónzalez-Pelayo
ELEnol Lopez
Enol Lopez
JBJavier Borge
Javier Borge
Noemí de-los-Santos-ÁlvarezNoemí de-los-Santos-Álvarez
Noemí de-los-Santos-Álvarez
LLLuis López
Luis López
The reaction of para-hydroxybenzyl alcohols with ferrocene in the presence of a catalytic amount of InCl3 provided ferrocenyl phenol derivatives, an interesting class of organometallic compounds with potential applications in medicinal chemistry. This transformation exhibited a reasonable substrate scope delivering the desired products in synthetically useful yields. Evidence of involvement of a para-quinone methide intermediate in this coupling process was also provided. Preliminary biological evaluation demonstrated that some of the ferrocene derivatives available by this methodology exhibit significant cytotoxicity against several cancer cell lines with IC50 values within the range of 1.07–4.89 μM.